Glucose effectiveness assessed under dynamic and steady state conditions - Comparability of uptake versus production components

被引:85
作者
Ader, M
Ni, TC
Bergman, RN
机构
[1] Dept. of Physiology and Biophysics, University of Southern California, School of Medicine, Los Angeles
[2] Univ. of S. California Sch. of Med., Dept. of Physiology and Biophysics, MMR 624, Los Angeles, CA 90033
关键词
glucose effectiveness; glucose turnover; dose response; mathematical modeling; intravenous glucose tolerance test; MINIMAL MODEL ANALYSIS; GLYCOGEN-SYNTHASE ACTIVITY; INSULIN SENSITIVITY; SKELETAL-MUSCLE; DIABETES-MELLITUS; LABELED IVGTT; FATTY-ACID; TOLERANCE; KINETICS; PLASMA;
D O I
10.1172/JCI119275
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Glucose tolerance is determined by both insulin action and insulin-independent effects, or ''glucose effectiveness,'' which includes glucose-mediated stimulation of glucose uptake (R(d)) and suppression of hepatic glucose output (HGO). Despite its importance to tolerance, controversy surrounds accurate assessment of glucose effectiveness. Furthermore, the relative contributions of glucose's actions on R(d) and HGO under steady state and dynamic conditions are unclear. We performed hyperglycemic clamps and intravenous glucose tolerance tests in eight normal dogs, and assessed glucose effectiveness by two independent methods. During clamps, glucose was raised to three successive 90-min hyperglycemic plateaus by variable labeled glucose infusion rate; glucose effectiveness (GE) was quantified as the slope of the dose-response relationship between steady state glucose and glucose infusion rate (GE(CLAMP(total))), R(d) (GE(CLAMP(uptake))) or HGO (GE(CLAMP(HGO))) During intravenous glucose tolerance tests, tritiated glucose (1.2 mu Ci/kg) was injected with cold glucose (0.3 g/kg); glucose and tracer dynamics were analyzed using a two-compartment model of glucose kinetics to obtain R(d) and HGO components of glucose effectiveness. All experiments were performed during somatostatin inhibition of islet secretion, and basal insulin and glucagon replacement. During clamps, R(d) rose from basal (2.54+/-0.20) to 3.95+/-0.54, 6.76+/-1.21, and 9.48+/-1.27 mg/min per kg during stepwise hyperglycemia; conversely, HGO declined to 2.06+/-0.17, 1.17+/-0.19, and 0.52+/-0.33 mg/min per kg. Clamp-based glucose effectiveness was 0.0451+/-0.0061, 0.0337+/-0.0060, and 0.0102+/-0.0009 dl/min per kg for GE(CLAMP(total)), GE(CLAMP(uptake)), and GE(CLAMP(HGO)), respectively. Glucose's action on R(d) dominated overall glucose effectiveness (72.2+/-3.3% of total), a result virtually identical to that obtained during intravenous glucose tolerance tests (71.6+/-6.1% of total). Both methods yielded similar estimates of glucose effectiveness. These results provide strong support that glucose effectiveness can be reliably estimated, and that glucose-stimulated R(d) is the dominant component during both steady state and dynamic conditions.
引用
收藏
页码:1187 / 1199
页数:13
相关论文
共 53 条
  • [1] IMPORTANCE OF GLUCOSE PER SE TO INTRAVENOUS GLUCOSE-TOLERANCE - COMPARISON OF THE MINIMAL-MODEL PREDICTION WITH DIRECT MEASUREMENTS
    ADER, M
    PACINI, G
    YANG, YJ
    BERGMAN, RN
    [J]. DIABETES, 1985, 34 (11) : 1092 - 1103
  • [2] PERIPHERAL EFFECTS OF INSULIN DOMINATE SUPPRESSION OF FASTING HEPATIC GLUCOSE-PRODUCTION
    ADER, M
    BERGMAN, RN
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (06): : E1020 - E1032
  • [3] ASSESSMENT OF INSULIN ACTION AND GLUCOSE EFFECTIVENESS IN DIABETIC AND NONDIABETIC HUMANS
    ALZAID, AA
    DINNEEN, SF
    TURK, DJ
    CAUMO, A
    COBELLI, C
    RIZZA, RA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) : 2341 - 2348
  • [4] ANDERSEN L, 1993, CLIN CHEM, V39, P578
  • [5] NEW TECHNIQUE FOR MAINTAINING AND MONITORING CONSCIOUS, STRESS-FREE RABBITS IN A STEADY-STATE - ITS USE IN THE DETERMINATION OF GLUCOSE KINETICS
    ATKINS, GL
    [J]. QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY AND COGNATE MEDICAL SCIENCES, 1980, 65 (01): : 63 - 75
  • [6] STABLE-LABEL INTRAVENOUS GLUCOSE-TOLERANCE TEST MINIMAL MODEL
    AVOGARO, A
    BRISTOW, JD
    BIER, DM
    COBELLI, C
    TOFFOLO, G
    [J]. DIABETES, 1989, 38 (08) : 1048 - 1055
  • [7] RATES OF NONINSULIN-MEDIATED GLUCOSE-UPTAKE ARE ELEVATED IN TYPE-II DIABETIC SUBJECTS
    BARON, AD
    KOLTERMAN, OG
    LAWRENCE, JB
    MANDARINO, J
    OLEFSKY, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) : 1782 - 1788
  • [8] RATES AND TISSUE SITES OF NON-INSULIN-MEDIATED AND INSULIN-MEDIATED GLUCOSE-UPTAKE IN HUMANS
    BARON, AD
    BRECHTEL, G
    WALLACE, P
    EDELMAN, SV
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (06): : E769 - E774
  • [9] ASSESSMENT OF INSULIN SENSITIVITY INVIVO
    BERGMAN, RN
    FINEGOOD, DT
    ADER, M
    [J]. ENDOCRINE REVIEWS, 1985, 6 (01) : 45 - 86
  • [10] QUANTITATIVE ESTIMATION OF INSULIN SENSITIVITY
    BERGMAN, RN
    IDER, YZ
    BOWDEN, CR
    COBELLI, C
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1979, 236 (06): : E667 - E677